We examined whether activated protein C (APC) reduces ischemia/reperfusion (I/R)–induced renal injury by inhibiting leukocyte activation. In a rat model, intravenous administration of APC markedly reduced I/R-induced renal dysfunction and histological changes, whereas intravenous administration of dansyl glutamylglycylarginyl chloromethyl ketone–treated factor Xa (DEGR-FXa; active-site–blocked factor Xa), heparin or diisopropyl fluorophosphate–treated APC (DIP-APC; inactive derivative of ARC) had no effect. Furthermore, APC significantly inhibited the I/R-induced decrease in renal tissue blood flow and the increase in the vascular permeability, whereas neither DEGR-FXa, heparin, nor DIP-APC produced such effects. Renal I/R-induced increases in plasma levels of fibrin degradation products were significantly inhibited by APC, DEGR-FXa, and heparin. These observations suggest that APC reduces I/R-induced renal injury independently of its anticoagulant effects but in a manner dependent on its serine protease activity. Renal levels of tumor necrosis factor- (TNF-), rat interleukin-8, and myeloperoxidase were significantly increased after renal I/R. These increases were significantly inhibited by APC but not by DEGR-FXa, heparin, or DIP-APC. Leukocytopenia produced effects similar to those of APC. These findings strongly suggest that APC protects against I/R-induced renal injury not by inhibiting coagulation abnormalities but by inhibiting activation of leukocytes that play an important role in I/R-induced renal injury. Inhibition of leukocyte activation by APC could be explained by the inhibitory activity of TNF-.

Activated protein C (APC) is an important physiologic anticoagulant that is generated from protein C by the action of the thrombin-thrombomodulin complex on endothelial cells.1 APC regulates the coagulation system by inactivating factors Va and VIIIa.1,2 Although its precise mechanisms of action have not been elucidated, APC was shown to reduce the mortality rate of baboons challenged with lethal doses ofEscherichia coli not by inhibiting the coagulation abnormality but by reducing organ damage.3,4 Because leukocytes have been implicated in the organ damage induced by endotoxin,5it is possible that APC reduces the organ damage by inhibiting leukocyte activation. In vitro studies indicated that APC inhibits the production of tumor necrosis factor α (TNF-α) by lipopolysaccharide (LPS)-activated monocytes.6,7 In studies with findings consistent with these observations, we demonstrated that APC reduced activated neutrophil–induced pulmonary vascular injury by inhibiting TNF-α production in rats given LPS.8 9 These results strongly suggest that, in sepsis, APC may be involved in regulation of the inflammatory response, as well as the coagulation system, through inhibition of TNF-α production.

Ischemia/reperfusion (I/R) is an important pathologic mechanism leading to organ failure in shock.10 TNF-α, by activating neutrophils, plays an important role in the development of I/R-induced organ damage.11 These observations strongly suggest that APC reduces the I/R-induced organ failure by inhibiting TNF-α production. I/R is also one of the most important pathologic mechanisms in the development of acute renal failure associated with renal transplantation and septic shock.12Activated neutrophils were implicated as participating in the pathogenesis of I/R-induced renal injury by damaging endothelial cells and thereby decreasing renal blood flow.10,13 In addition, fibrin deposition in the glomerulus contributed to a decrease in glomerular filtration fraction in animals subjected to renal I/R.14 15 

These findings suggest that APC may reduce I/R-induced renal injury by inhibiting leukocyte activation as well as by attenuating the coagulation abnormality. In this study, we examined whether APC reduces I/R-induced renal injury in rats. To investigate the mechanism by which APC diminishes renal injury, we analyzed the effects of APC, as well as the effects of an inactive derivative of factor Xa that inhibits thrombin generation selectively, heparin, and inactivated APC, on I/R-induced renal injury in our rat model.

Protein C was purified from human plasma and activated by thrombin as described previously.16 Nitrogen mustard (NM), diisopropyl fluorophosphate (DIP), Evans blue dye, and myeloperoxidase (MPO) were purchased from Sigma (St Louis, MO); dansyl glutamylglycylarginyl chloromethyl ketone (DEGR) was from Calbiochem (San Diego, CA); and heparin was from Novo Nordisk (Gentofte, Denmark). All other reagents were of analytical grade.

Preparation of DEGR-treated factor Xa

DEGR-treated factor Xa (DEGR-FXa), a selective inhibitor of thrombin generation,17 was prepared as described previously. Briefly, factor X was purified from human plasma and activated with Russell viper venom.18,19 Activated factor X was inactivated by incubation with a 20-fold molar excess of DEGR for 30 minutes at 25°C. The mixture was then subjected to extensive dialysis against a solution containing 20 mmol/L Tris-hydrochloric acid (pH 7.4) and 100 mmol/L sodium chloride. DEGR-FXa competes with intact factor Xa for prothrombinase complex formation.20 DEGR-FXa generated as described above showed no clotting activity and a prolonged activated partial thromboplastin time in a concentration-dependent manner (0 to 300 μg/mL).

Preparation of DIP-treated APC (DIP-APC)

APC was inactivated by using DIP, according to a previously described method.6 Briefly, APC (1 mg/mL) was incubated with 10 mmol/L of DIP in phosphate-buffered saline (pH 7.4) for 2 hours and dialyzed extensively against the same buffer. The effectiveness of inactivation of APC by DIP treatment was monitored amidolytically by measuring the rate of hydrolysis of the chromogenic substrate S-2366 (Chromogenix AB, Stockholm, Sweden) at 405 nm. The activity of APC after the inactivation procedure was less than 1%.

Reduction in the number of circulating leukocytes by NM

NM was used to produce leukocytopenia in rats. NM (1 mg/kg of body weight) or saline was administered intravenously to the animals 2 days before the experiment.21 On the day of the experiment, the number of circulating leukocytes was 10 722 ± 1041 in controls (n = 6) and 3100 ± 371 in NM-treated rats (n = 6;P < .01 compared with control value).

Animal model of I/R-induced renal injury

Specific pathogen-free male Wistar rats (Nihon SLC, Hamamatsu, Japan) weighing 180 to 220 g were used throughout the experiments. Animal care and handling were performed in accordance with the guidelines of the National Institutes of Health. The rats were given water but not food for 16 hours before the experiments. The renal I/R protocol was as follows.22 The rats were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg; Abbott Laboratories, North Chicago, IL). In all rats, a midline incision was made, the left kidney was mobilized, the left renal vessels were ligated, and a left nephrectomy was performed. In the I/R groups, the right pedicle was clamped with a noncrushing microvascular clamp for 60 minutes. The presence of ischemia was visually confirmed by observing blanching of the kidney. During the period of renal ischemia, the rats were covered with plastic wrap to prevent evaporation. APC (100 μg/kg), DEGR-FXa (1 mg/kg), heparin (300 U/kg), DIP-APC (100 μg/kg), or saline was administered intravenously 30 minutes before reperfusion. After 60 minutes of ischemia, the clamps were removed, the wounds were closed with 3-0 silk, and the animals were returned to their cages. The rats in the sham-operation group underwent the same procedure except that clamping was not done. At specified times after reperfusion, animals were anesthetized by intraperitoneal administration of pentobarbital (50 mg/kg) and killed by exsanguination from the abdominal aorta. Blood was collected in tubes and centrifuged at 2000g for 10 minutes. Serum levels of blood urea nitrogen (BUN) and creatinine were measured with standard urease assays and picric acid reactions.11 Serum levels of fibrin degradation products [FDP(E)] were measured with a latex agglutination assay, as described previously.23 

Determination of renal microvascular permeability

Renal vascular permeability was assessed by a dye method in which extravasated dye was measured as described previously.24Briefly, Evans blue dye (25 μg/kg) was injected intravenously 10 minutes before the rats were killed by exsanguination from the abdominal aorta. The kidneys were removed, weighed, and put into tubes containing 5 mL of dimethylformamide (Wako, Osaka, Japan). After centrifugation (2000g for 10 minutes), the concentration of Evans blue dye extracted in the dimethylformamide was measured with a spectrophotometer (DU-54; Beckman, Irvine, CA) at a wavelength of 610 nm by comparison with results obtained with standards of known concentration. The Evans blue dye concentration for each sample was expressed in micrograms per gram of tissue.

Measurement of blood flow in renal tissue

The rats were anesthetized with pentobarbital sodium (50 mg/kg given intraperitoneally), laparotomy was performed, and the blood flow in renal tissue was measured by using a laser Doppler flowmeter (ALF21N; Advance, Tokyo, Japan), as described previously.25 The Doppler probe was directed toward the cortex. Renal tissue blood flow was measured from 30 minutes before ischemia until 3 hours after reperfusion. Electrical signals from the probe were digitized and recorded in real time by using a Macintosh Performa 6310 and MacLab software.26 Results were expressed as percentages of the preischemia levels.

Histopathological studies of the kidneys

The rats' kidneys were removed 24 hours after reperfusion, fixed in 10% formalin, embedded in paraffin, sectioned (5-μm thicknesses), and stained with hematoxylin and eosin. Histological changes were evaluated by assessments of neutrophil accumulation, tubular necrosis, and vascular congestion in the outer medulla, according to the methods described by Kelly et al11 and Chiao et al,13 with some modifications. Neutrophil accumulation was evaluated by counting the neutrophils in the outer medulla, whereas vascular congestion was assessed by counting the erythrocytes in the outer medulla. The cells were counted by using an eyepiece graticule (magnification ×400). Tubular necrosis was evaluated by determining the percentage of tubules in the outer medulla in which epithelial necrosis or necrotic debris was observed. Each variable was evaluated in 20 high-power fields. Samples were analyzed by a pathologist with no knowledge of the experiment group to which the rat belonged.

Measurement of renal MPO activity

Renal MPO activity was measured as described previously.21 The rats were killed at specified times after reperfusion. The kidneys were removed, weighed, and homogenized with a homogenizer (Physcotron; Nition, Tokyo, Japan) in 10% (wt/vol) homogenization buffer (50 mmol/L phosphate buffer [pH 6.0] containing 0.5% hexadecyltrimethylammonium bromide) and sonicated for 20 seconds. After centrifugation (4500g for 20 minutes at 4°C), 0.1 mL of supernatant was added to 0.55 mL of 0.1 mol/L phosphate buffer (pH 6.0) containing 1.25 mg/mL o-dianisidine and 0.05% hydrogen peroxide. After 5 minutes, the change in absorbance at 460 nm was measured with a spectrophotometer. Purified MPO was used as a standard. Results were expressed as units of MPO activity per gram of tissue.

Measurement of renal levels of cytokines

At specified times after reperfusion, the kidneys were removed, weighed, and homogenized with a homogenizer using 0.1 mol/L phosphate buffer (pH 7.4) containing 0.05% (wt/vol) of sodium azide at 4°C. Homogenates were then sonicated for 20 seconds and centrifuged (2000g for 10 minutes at 4°C). The supernatants were stored at −80°C until measurement of cytokines. Renal levels of TNF-α and rat interleukin 8 (IL-8) were measured with use of a rat TNF-α enzyme-linked immunosorbent assay (ELISA) kit (Genzyme, Cambridge, MA) and a rat IL-8 ELISA kit (Amersham, Little Chalfont, UK), respectively. Results were expressed as picograms of the measured cytokine per gram of tissue.

Statistical analysis

Data are presented as mean ± SD values. Results were compared with an unpaired t test (single comparison) or analysis of variance followed by the Scheffe post hoc test (multiple comparisons). A level of P < .05 was considered significant.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced renal dysfunction

Serum levels of BUN and creatinine were significantly higher after reperfusion in rats that had I/R than in rats that had a sham operation and peaked at 24 hours after reperfusion (Figure1). Intravenous administration of APC significantly inhibited the increases in serum levels of BUN and creatinine 24 hours after reperfusion, but neither DEGR-FXa, heparin, nor DIP-APC had any effect (Figure 2). The levels of BUN and creatinine 24 hours after reperfusion were significantly decreased in rats with leukocytopenia (Figure 2).

Fig. 1.

Changes in serum levels of blood urea nitrogen (BUN) and creatinine in rats after renal ischemia and reperfusion (I/R).

Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Serum levels of BUN (A) and creatinine (B) were measured before ischemia (Pre), and 3, 6, 12, and 24 hours after reperfusion. Rats in the sham-operation group had uninephrectomy but not I/R. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5); and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group.

Fig. 1.

Changes in serum levels of blood urea nitrogen (BUN) and creatinine in rats after renal ischemia and reperfusion (I/R).

Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Serum levels of BUN (A) and creatinine (B) were measured before ischemia (Pre), and 3, 6, 12, and 24 hours after reperfusion. Rats in the sham-operation group had uninephrectomy but not I/R. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5); and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group.

Close modal
Fig. 2.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced increases in BUN and creatinine.

Serum levels of BUN (A) and creatinine (B) were measured 24 hours after reperfusion in rats subjected to 60 minutes of renal ischemia followed by reperfusion. Animals were intravenously administered saline, APC (100 μg/kg of body weight), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Fig. 2.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced increases in BUN and creatinine.

Serum levels of BUN (A) and creatinine (B) were measured 24 hours after reperfusion in rats subjected to 60 minutes of renal ischemia followed by reperfusion. Animals were intravenously administered saline, APC (100 μg/kg of body weight), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Close modal

Histological changes

Histological examinations of kidneys were performed 24 hours after reperfusion (Figure 3). Microscopical assessment of renal tissue revealed severe tubular necrosis, loss of brush border, necrosis and sloughing of tubular cells, and obstructing cast in the outer medulla (Figures 3B and 3I); such changes were not observed in rats in the sham-operation group (Figures 3A and3H). Intravenous administration of APC markedly reduced these histological changes (Figures 3C and 3J), whereas neither DEGR-FXa (Figures 3D and 3K), heparin (Figures 3E and 3L), nor DIP-APC (Figures3F and 3M) produced such an effect. The I/R-induced histological changes were also reduced by leukocytopenia (Figures 3G and 3N). Tubular necrosis was significantly diminished by APC administration and leukocytopenia but was not reduced in rats given either DEGR-FXa or heparin (Table 1). Administration of DIP-APC also did not attenuate this change (Table 1). Neutrophil accumulation in the vasa recta of the outer medulla and vascular congestion were also found after I/R of the kidney (Figures 3B and 3I). When analyzed quantitatively, renal neutrophil accumulation and the vascular congestion induced by renal I/R were significantly reduced in rats given APC and in those with leukocytopenia (Table 1). However, neither DEGR-FXa, heparin, nor DIP-APC affected the renal changes (Table 1). Fibrin deposition was not observed in kidneys from any group.

Fig. 3.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on renal histological feature in rats that had I/R.

Rats were subjected to 60 minutes of renal ischemia followed by reperfusion. Results are shown in rats in the sham-operation group (A and H), rats treated with I/R plus saline (B and I), rats treated with I/R plus APC (C and J); rats treated with I/R plus DEGR-FXa (D and K), rats treated with I/R plus heparin (E and L), rats treated with I/R plus DIP-APC (F and M), and rats treated with I/R and induction of leukocytopenia (G and N). For A, B, C, D, E, F, G, original magnification ×100; for H, I, J, K, L, M, and N, original magnification ×400.

Fig. 3.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on renal histological feature in rats that had I/R.

Rats were subjected to 60 minutes of renal ischemia followed by reperfusion. Results are shown in rats in the sham-operation group (A and H), rats treated with I/R plus saline (B and I), rats treated with I/R plus APC (C and J); rats treated with I/R plus DEGR-FXa (D and K), rats treated with I/R plus heparin (E and L), rats treated with I/R plus DIP-APC (F and M), and rats treated with I/R and induction of leukocytopenia (G and N). For A, B, C, D, E, F, G, original magnification ×100; for H, I, J, K, L, M, and N, original magnification ×400.

Close modal
Table 1.

Tubular necrosis, neutrophil accumulation, and congestion in the outer medulla in rats subjected to renal ischemia followed by reperfusion

Treatment Group Tubular Necrosis (%) Neutrophils (/HPF) Erythrocytes (/HPF)
Sham operation  0.0 ± 0.0 0.1 ± 0.1  80.3 ± 17.1  
I/R + saline 84.8 ± 9.1* 8.3 ± 3.7* 352.7 ± 48.1* 
I/R + APC  51.4 ± 11.8 1.9 ± 1.6 183.6 ± 65.9 
I/R + DEGR-FXa  82.0 ± 6.8* 8.2 ± 3.1* 343.2 ± 67.3* 
I/R + heparin 81.6 ± 7.5* 7.8 ± 2.6* 304.4 ± 44.6* 
I/R + DIP-APC  80.0 ± 8.7* 8.3 ± 3.3* 345.6 ± 70.2* 
I/R + leukocytopenia  32.6 ± 12.9 0.8 ± 0.7 175.8 ± 80.4 
Treatment Group Tubular Necrosis (%) Neutrophils (/HPF) Erythrocytes (/HPF)
Sham operation  0.0 ± 0.0 0.1 ± 0.1  80.3 ± 17.1  
I/R + saline 84.8 ± 9.1* 8.3 ± 3.7* 352.7 ± 48.1* 
I/R + APC  51.4 ± 11.8 1.9 ± 1.6 183.6 ± 65.9 
I/R + DEGR-FXa  82.0 ± 6.8* 8.2 ± 3.1* 343.2 ± 67.3* 
I/R + heparin 81.6 ± 7.5* 7.8 ± 2.6* 304.4 ± 44.6* 
I/R + DIP-APC  80.0 ± 8.7* 8.3 ± 3.3* 345.6 ± 70.2* 
I/R + leukocytopenia  32.6 ± 12.9 0.8 ± 0.7 175.8 ± 80.4 

Rats were subjected to 60 minutes of renal ischemia followed by reperfusion. Kidney samples were obtained 24 hours after reperfusion. Data are expressed as mean ± SD values from 5 experiments. HPF indicates high-power field; I/R, ischemia/reperfusion; APC, activated protein C; DEGR-FXa, dansyl glutamylglycylarginyl chloromethyl ketone–treated factor Xa; and DIP-APC, diisopropyl fluorophosphate–treated APC.

*

P < .01 compared with sham operation group.

P < .01 compared with I/R + saline group.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced increases in serum FDP(E) levels

Serum concentrations of FDP(E) were significantly higher after reperfusion in rats that had I/R than in rats that had a sham operation and peaked at 24 hours after reperfusion (Figure4A). The increases in serum FDP(E) levels 24 hours after reperfusion were significantly inhibited by administration of APC, DEGR-FXa, or heparin but not by DIP-APC (Figure4B). Leukocytopenia significantly inhibited the increase in serum FDP(E) levels in rats subjected to renal I/R (Figure 4B).

Fig. 4.

Changes in serum levels of FDP(E) in rats that had renal I/R, and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced increases in serum levels of FDP(E) 24 hours after reperfusion.

(A) Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Serum levels of FDP(E) were measured before ischemia (Pre), and 3, 6, 12, 24, and 48 hours after reperfusion. Rats in the sham-operation group had uninephrectomy only. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5); and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group. (B) Rats were given intravenously administered saline, APC (100 μg/kg), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Fig. 4.

Changes in serum levels of FDP(E) in rats that had renal I/R, and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on I/R-induced increases in serum levels of FDP(E) 24 hours after reperfusion.

(A) Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Serum levels of FDP(E) were measured before ischemia (Pre), and 3, 6, 12, 24, and 48 hours after reperfusion. Rats in the sham-operation group had uninephrectomy only. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5); and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group. (B) Rats were given intravenously administered saline, APC (100 μg/kg), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Close modal

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the changes in renal tissue blood flow in rats that had renal I/R

Renal tissue blood flow decreased to approximately 40% of the preischemia level 3 hours after reperfusion (Figure5). Intravenous administration of APC significantly inhibited the I/R-induced reduction in blood flow. No significant effect was observed in rats given DEGR-FXa, heparin, or DIP-APC (Figure 5). The reduction in blood flow was significantly decreased by leukocytopenia (Figure 5).

Fig. 5.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the renal I/R-induced decrease in renal tissue blood flow in rats.

Rats were subjected to 60 minutes of renal ischemia followed by reperfusion. Renal tissue blood flow was measured from 30 minutes before ischemia until 3 hours after reperfusion. Data are expressed as mean ± SD values from 5 experiments. Closed circles indicate saline-treated rats; open circles, APC-treated rats; closed squares, DEGR-FXa–treated rats; open squares, heparin-treated rats; closed triangles, DIP-APC–treated rats; and open triangles, leukocytopenic rats. *P < .01 compared with saline-treated rats that had I/R.

Fig. 5.

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the renal I/R-induced decrease in renal tissue blood flow in rats.

Rats were subjected to 60 minutes of renal ischemia followed by reperfusion. Renal tissue blood flow was measured from 30 minutes before ischemia until 3 hours after reperfusion. Data are expressed as mean ± SD values from 5 experiments. Closed circles indicate saline-treated rats; open circles, APC-treated rats; closed squares, DEGR-FXa–treated rats; open squares, heparin-treated rats; closed triangles, DIP-APC–treated rats; and open triangles, leukocytopenic rats. *P < .01 compared with saline-treated rats that had I/R.

Close modal

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the increase in renal vascular permeability after renal I/R

Renal vascular permeability as assessed by an increase in leakage of Evans blue dye was significantly higher after reperfusion in rats that had I/R than in rats that had a sham operation and peaked at 6 hours after reperfusion (Figure6A). Both administration of APC and leukocytopenia significantly inhibited the increases in renal vascular permeability 6 hours after reperfusion, whereas neither DEGR-FXa, heparin, nor DIP-APC had any effect (Figure 6B).

Fig. 6.

Changes in renal vascular permeability in rats after renal I/R, and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the I/R-induced increase in vascular permeability observed 6 hours after reperfusion.

(A) Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Renal vascular permeability was evaluated by assessing leakage of Evans blue dye administered intravenously 10 minutes before the rats were killed. Vascular permeability was measured before ischemia (Pre) and 3, 6, 12, and 24 hours after reperfusion. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5), and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group. (B) Rats were given intravenously administered saline, APC (100 μg/kg), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Fig. 6.

Changes in renal vascular permeability in rats after renal I/R, and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the I/R-induced increase in vascular permeability observed 6 hours after reperfusion.

(A) Rats were subjected to uninephrectomy and 60 minutes of renal ischemia followed by reperfusion. Renal vascular permeability was evaluated by assessing leakage of Evans blue dye administered intravenously 10 minutes before the rats were killed. Vascular permeability was measured before ischemia (Pre) and 3, 6, 12, and 24 hours after reperfusion. Data are expressed as mean ± SD values. Open circles indicate rats in the sham-operation group (n = 5), and closed circles, rats that had I/R (n = 5). *P < .01 compared with the sham-operation group. (B) Rats were given intravenously administered saline, APC (100 μg/kg), DEGR-FXa (1 mg/kg), heparin (300 U/kg), or DIP-APC (100 μg/kg) 30 minutes before reperfusion. Leukocytopenia was induced by administration of nitrogen mustard. Data are expressed as mean ± SD values. Values in parentheses indicate the number of animals in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Close modal

Effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on renal levels of TNF-, rat IL-8, and MPO after renal I/R in rats

Renal levels of TNF-α and rat IL-8 in rats subjected to renal I/R increased, reached their peaks at 3 hours after reperfusion, and decreased gradually thereafter (Figures 7A and 7B). Renal levels of MPO also increased after reperfusion and peaked at 6 hours after reperfusion (Figure 7C). Administration of APC significantly inhibited the I/R-induced increases in renal levels of TNF-α and rat IL-8 3 hours after reperfusion, whereas neither DEGR-FXa, heparin, nor DIP-APC produced such effects (Figures 7D and7E). Although APC inhibited the I/R-induced increases in renal levels of MPO 6 hours after reperfusion, neither DEGR-FXa, heparin, nor DIP-APC had any effect (Figure 7F). Renal tissue levels of TNF-α and rat IL-8 3 hours after reperfusion were significantly lower in rats with leukocytopenia than in those given saline (Figures 7D and 7E). The I/R-induced increases in renal levels of MPO 6 hours after reperfusion were significantly inhibited in rats with leukocytopenia (Figure7F).

Fig. 7.

Changes in renal tissue levels of cytokines and MPO after renal I/R in rats and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia.

Shown are the renal tissue levels of tumor necrosis factor-α (TNF-α) (A), rat interleukin 8 (IL-8) (B), and MPO (C) after renal I/R and the effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the I/R-induced increases in renal tissue levels of TNF-α (D), rat IL-8 (E), and MPO (F) after reperfusion. Renal tissue levels of TNF-α, rat IL-8, and MPO were measured before ischemia (Pre) and 3, 6, 12, and 24 hours after reperfusion or sham operation. Renal tissue levels of TNF-α and rat IL-8 were measured 3 hours after reperfusion; renal tissue levels of MPO were determined 6 hours after reperfusion. Data are expressed as mean ± SD values. Values in parentheses indicate the number of rats in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Fig. 7.

Changes in renal tissue levels of cytokines and MPO after renal I/R in rats and effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia.

Shown are the renal tissue levels of tumor necrosis factor-α (TNF-α) (A), rat interleukin 8 (IL-8) (B), and MPO (C) after renal I/R and the effects of APC, DEGR-FXa, heparin, DIP-APC, and leukocytopenia on the I/R-induced increases in renal tissue levels of TNF-α (D), rat IL-8 (E), and MPO (F) after reperfusion. Renal tissue levels of TNF-α, rat IL-8, and MPO were measured before ischemia (Pre) and 3, 6, 12, and 24 hours after reperfusion or sham operation. Renal tissue levels of TNF-α and rat IL-8 were measured 3 hours after reperfusion; renal tissue levels of MPO were determined 6 hours after reperfusion. Data are expressed as mean ± SD values. Values in parentheses indicate the number of rats in each experiment. *P < .01 compared with the sham-operation group; †P < .01 compared with the I/R plus saline group.

Close modal

In this study, we demonstrated that APC, a physiologic anticoagulant, reduced I/R-induced renal dysfunction and histological changes in rats. Although APC, DEGR-FXa (a selective inhibitor of thrombin generation), and heparin significantly inhibited the I/R-induced increases in serum levels of FDP(E), neither DEGR-FXa nor heparin diminished the I/R-induced renal dysfunction. These observations strongly suggest that the anticoagulant effect of APC may not have contributed to the reduction in I/R-induced renal injury. Because DIP-APC, an inactive derivative of APC, did not diminish the I/R renal injury, the serine protease activity of APC may be critical for its protective role.

Leukocytopenia did reduce I/R-induced renal injury, suggesting that leukocytes are critically involved in the pathologic process of such an injury. Results of a study by Kelly et al27 demonstrating that inhibition of neutrophil adhesion prevents ischemic renal injury are consistent with this hypothesis. Activated neutrophils release various inflammatory mediators that are capable of damaging endothelial cells.28 These mediators, which include neutrophil elastase and oxygen free radicals, increase vascular permeability,10,29 thereby leading to a reduction in tissue blood flow.30 In accordance with this hypothesis, leukocytopenia significantly inhibited both the increase in renal vascular permeability and the reduction in renal tissue blood flow induced by I/R in the rat model in the current study.

A preliminary experiment by our group demonstrated that ONO-5046, a selective inhibitor of neutrophil elastase,31 significantly inhibited the I/R-induced decrease in renal tissue blood flow by diminishing the increase in renal vascular permeability in the same animal model used here. Thus, it is possible that activation of neutrophils is an important cause of the development of I/R-induced renal injury through a reduction in renal tissue blood flow. Although APC significantly inhibited both the increase in I/R-induced renal vascular permeability and the reduction in renal tissue blood flow, neither DEGR-FXa, heparin, nor DIP-APC had any effect, suggesting that APC may prevent the I/R-induced decrease in renal tissue blood flow in a manner independent of its anticoagulant effects, that is, by means of some other biologic activity or activities that depend on its serine protease activity. Furthermore, it is possible that the preventive effect of APC might include the inhibition of neutrophil activation.

TNF-α activates neutrophils to release inflammatory mediators.32 Because TNF-α production is enhanced in I/R-induced renal injury,33 it is possible that TNF-α activates neutrophils to promote the release of inflammatory mediators, which may decrease renal tissue blood flow. In this study, leukocytopenia inhibited the I/R-induced increases in renal levels of both TNF-α and rat IL-8 and decreased the I/R-induced renal accumulation of neutrophils. Thus, inhibition of TNF-α production may prevent the subsequent neutrophil activation that leads to a reduction in renal tissue blood flow. Although APC does not inhibit the activation of neutrophils directly, it inhibits TNF-α production by LPS-stimulated monocytes.9 Furthermore, APC was shown to inhibit the increase in plasma levels of TNF-α in rats given LPS,9 suggesting that APC may inhibit TNF-α production and thereby inhibit neutrophil activation. In accordance with this hypothesis, we found in this study that APC inhibited the I/R-induced increases in renal levels of TNF-α and rat IL-8, as well as the renal accumulation of neutrophils. Moreover, neither DEGR-FXa, heparin, nor DIP-APC inhibited these increases, suggesting that APC may reduce I/R-induced renal injury by inhibiting neutrophil activation by means of inhibition of TNF-α production. In addition, these protective effects of APC may be mediated not by its anticoagulant effect but by its serine protease activity. Taken together, these observations suggest that inhibition of leukocyte activation could be one possible therapeutic mechanism by which APC reduces I/R-induced renal injury.

The mechanism by which APC inhibits TNF-α production by activated monocytes is not well understood. We previously showed that the serine protease activity of APC is important for the inhibition of TNF-α production by monocytes stimulated with LPS in vitro.9 Grey et al6 demonstrated that APC suppresses the production of TNF-α by LPS-stimulated monocytes by inhibiting the coupling of LPS and CD14, which stimulates production of cytokines, and this suppressive activity of APC depends on its serine protease activity. However, inhibition of TNF-α production by APC in the pathologic condition of I/R-induced tissue injury may not be related to inhibition of the coupling of LPS and CD14. Thus, alternative mechanisms may explain the inhibition of TNF-α production by APC in I/R-induced renal injury. Because oxygen free radicals play a role in I/R-induced tissue injury by stimulating monocytes to produce TNF-α,34 it is possible that APC inhibits oxygen free radical–induced TNF-α production by monocytes. We are currently investigating this possibility.

Plasma-derived APC concentrates have been shown to be effective in alleviating coagulation abnormalities in patients with disseminated intravascular coagulation (DIC).35 Because APC may be effective in reducing I/R-induced tissue injury, it can be useful not only for attenuating the coagulation abnormality but also for diminishing organ injury in patients with DIC associated with shock.

Reprints:Kenji Okajima, Department of Laboratory Medicine, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto 860-0811, Japan; e-mail: whynot@kaiju.medic.kumamoto-u.ac.jp.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Walker
FJ
Sexton
PW
Esmon
CT
The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V.
Biochim Biophys Acta.
571
1979
333
2
Esmon
CT
The protein C anticoagulant pathway.
Arterioscler Thromb.
12
1992
135
3
Taylor
FB
Jr
Chang
A
Esmon
CT
et al
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
J Clin Invest.
79
1987
918
4
Taylor
FB
Jr
Chang
AC
Peer
GT
et al
DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.
Blood.
78
1991
364
5
St John
RC
Dorinsky
PM
Immunologic therapy for ARDS, septic shock and multiple organ failure.
Chest.
103
1993
932
6
Grey
S
Hau
H
Salem
HH
Hancock
WW
Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-γ, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction.
Transplant Proc.
25
1993
2913
7
Grey
ST
Tsuchida
A
Hau
H
Orthner
CL
Salem
HH
Hancock
WW
Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester.
J Immunol.
153
1994
3664
8
Murakami
K
Okajima
K
Uchiba
M
et al
Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Blood.
87
1996
642
9
Murakami
K
Okajima
K
Uchiba
M
et al
Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.
Am J Physiol.
272
1997
L197
10
Thadhani
R
Pascual
M
Bonventre
JV
Acute renal failure.
N Engl J Med.
334
1996
1448
11
Kelly
KJ
Williams
WW
Jr
Colvin
RB
et al
Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.
J Clin Invest.
97
1996
1056
12
Bonventre
JV
Mechanisms of acute renal failure.
Kidney Int.
43
1993
1160
13
Chiao
H
Kohda
Y
McLeroy
P
Craig
L
Housini
I
Star
RA
α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.
J Clin Invest.
99
1997
1165
14
Losonczy
G
Jr
Early postischaemic renal fibrin deposition and reduction of glomerular filtration rate in the rat: effect of the defibrinating agent Arwin.
Acta Physiol Hung.
66
1985
183
15
Druid
H
Eneström
S
Rammer
L
Effect of anticoagulation upon nephron obstruction in experimental acute ischaemic renal failure: a morphological study.
Int J Exp Pathol.
79
1998
55
16
Okajima
K
Koga
S
Kaji
M
et al
Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects.
Thromb Haemost.
63
1990
48
17
Nesheim
ME
Kettner
C
Shaw
E
Mann
KG
Cofactor dependence of factor Xa incorporation into the prothrombinase complex.
J Biol Chem.
256
1981
6537
18
Bajaj
SP
Rapaport
SI
Prodanos
CA
A simplified procedure for purification of human prothrombin, factor IX and factor X.
Prep Biochem.
11
1981
397
19
Morita
T
Jackson
CM
Localization of the structural difference between bovine blood coagulation factors X1 and X2 to tyrosine 18 in the activation peptide.
J Biol Chem.
261
1986
4008
20
Mann
KG
Membrane-bound enzyme complexes in blood coagulation. In Spaet TH, ed. Progress in Hemostasis and Thrombosis.
7
1984
1
24
Grune & Stratton
New York, NY
21
Taoka
Y
Okajima
K
Uchiba
M
et al
Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes.
J Neurosci.
18
1998
1393
22
Rabb
H
Mendiola
CC
Saba
SR
et al
Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury.
Biochem Biophys Res Commun.
211
1995
67
23
Okajima
K
Ueyama
H
Hashimoto
Y
et al
Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Thromb Haemost.
61
1989
20
24
Plante
GE
Bissonnette
M
Sirois
MG
Regoli
D
Sirois
P
Renal permeability alteration precedes hypertension and involves bradykinin in the spontaneously hypertensive rat.
J Clin Invest.
89
1992
2030
25
Hansell
P
Nygren
A
Ueda
J
Influence of verapamil on regional blood flow: a study using multichannel laser-Doppler flowmetry.
Acta Physiol Scand.
139
1990
15
26
Gurbanov
K
Rubinstein
I
Hoffman
A
Abassi
Z
Better
OS
Winaver
J
Differential regulation of renal regional blood flow by endothelin-1.
Am J Physiol.
271
1996
F1166
27
Kelly
KJ
Williams
WW
Jr
Colvin
RB
Bonventre
JV
Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.
Proc Natl Acad Sci U S A.
91
1994
812
28
Inauen
W
Granger
DN
Meininger
CJ
Schelling
ME
Granger
HJ
Kvietys
PR
An in vitro model of ischemia/reperfusion-induced microvascular injury.
Am J Physiol.
259
1990
G134
29
Bonventre
JV
Colvin
RB
Adhesion molecules in renal disease.
Curr Opin Nephrol Hypertens.
5
1996
254
30
Liu
W
Okajima
K
Murakami
K
Harada
N
Isobe
H
Irie
T
Role of neutrophil elastase in stress-induced gastric mucosal injury in rats.
J Lab Clin Med.
132
1998
432
31
Kawabata
M
Suzuki
M
Sugitani
M
Imaki
K
Toda
M
Miyamoto
T
ONO-5046, a novel inhibitor of human neutrophil elastase.
Biochem Biophys Res Commun.
177
1991
814
32
Pober
JS
Cotran
RS
Cytokines and endothelial cell biology.
Physiol Rev.
70
1990
427
33
Daemen
MA
van de Ven
MW
Heineman
E
Buurman
WA
Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury.
Transplantation.
27
1999
792
34
Remick
DG
Villarete
L
Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates.
J Leukoc Biol.
59
1996
471
35
Okajima
K
Imamura
H
Koga
S
Inoue
M
Takatsuki
K
Aoki
N
Treatment of patients with disseminated intravascular coagulation by protein C.
Am J Hematol
33
1990
277
Sign in via your Institution